Israeli medical device maker NI Medical Ltd. will open an office in the Akron Global Business Accelerator, likely during the first half of the year, where it could employ up to 30 workers in four years. But wooing the maker of an innovative heart monitoring device was a group effort.

CardioInsight Technologies Inc. has raised $5.7 million in an ongoing funding round to help commercialize its heart-mapping technology. The Cleveland company’s electrocardiographic mapping technology could help diagnose and treat electrical abnormalities of the heart, such as heart failure and arrhythmia.

Armed with a $100,000 grant from Lorain County Community College’s Innovation Fund, ReQuisite Biomedical would like to raise another $800,000 before relocating, said co-founder and Chief Executive John Foley.

The Cleveland Clinic is looking for tenants to occupy the Global Cardiovascular Innovation Center it’s building on the southern edge of its main campus. The $19 million project at East 101st Street and Cedar Road will host wet laboratories and offices, conference rooms and informal meeting areas, artwork and sophisticated teleconferencing and audio-visual technologies when it opens, likely in May.

Clear Catheter Systems Inc. has won the 2009 EACTS TechnoCollege Innovation Award for its investigational catheter tube-clearing system, PleuraFlow.

EarlySense, which monitors a series of vital signs in hospitals and home health care settings, is among four companies that will share $2 million in grants from the Global Cardiovascular Innovation Center (GCIC).

BioOhio — Ohio’s bioscience industry developer — and the Global Cardiovascular Innovation Center (GCIC) housed at the Cleveland Clinic have published a bigger and better online directory of the state’s companies, organizations and research centers that are involved in the biosciences. BioOhio will hold a webinar at 10 a.m. on Wednesday, Sept. 16, to demonstrate directory searches and queries, and answer questions.

The center invested a total of $1 million in Cardiostar Ltd., Sensible Medical Innovations Ltd. and Vasostar Ltd. Cardiostar is developing a non-invasive way to monitor blood-pressure beat-to-beat, Sensible Medical’s device works during congestive heart failure to, among other things, more quickly detect lungs filling with fluid; and Vasostar’s catheter would better break up artery blockages known as total chronic occlusion.

An Ohio State University researcher is developing an MRI-compatible treadmill that could better measure heart function and blood flow at the peak of stress. The device, which could cut down on multiple tests and catch some heart problems earlier, may be ready for clinical testing in three months.

The Global Cardiovascular Innovation Center in Cleveland is looking for young companies that need financial and developmental help to take their heart-related products to market. The center’s next grant round starts on May 8.